Generic Drugmakers Struggle Despite Us Push For Copycats | Latest News RSS feed

Generic Drugmakers Struggle Despite Us Push For Copycats - Latest News


Amgen Wins Reprieve on Its 2nd-Best-Selling Drug

That may mean it's only a matter of time before generic drug companies, including Mylan (NASDAQ: MYL), win FDA approval of biosimilar copycats ... to the tune of about $12 million per day. Despite Myl... read more

Generic drugs' troubled source

As U.S. regulators push hundreds of new generic drugs to market in an effort to drive down prices, the industry is facing a continuing problem in India, where many copycat medicines ... sending produc... read more

Drug companies rake in billions off ‘snort-proof’ opioids

But it’s also a multibillion-dollar sales opportunity, offering drugmakers the potential to wipe out lower-cost generic competitors and lock ... will give drugmakers momentum to successfully push for ... read more

Looking for another news?


Analysis: Roche stays a step ahead of copycat drugmakers

Generic copies, therefore, are more difficult to develop and market. While rival drugmakers ... Roche to push back to early 2016 the date it expects the first MabThera biosimilar, meaning that sales o... read more


FTC sees return of pacts to thwart generic competition

The US Federal Trade Commission says the top pharmaceutical companies have resumed the practice of paying generic drug manufacturers to keep copycat versions of brandname medicines off the market, des... read more

KHN Morning Briefing

Despite heavy opposition from the pharmaceutical ... a brand-name drug maker reaches a settlement with a generic rival in exchange for ending patent litigation and an agreement for launching a copycat ... read more

A Fearless Fight for a Safer World

“It is becoming increasingly likely that the solution to this huge problem is not going to be found with anything less than a national program,” we said, despite opposition ... tactics against less ex... read more

Talking Point: Nintendo Should Aim to Produce Mature, Genre-Defining Storytelling Experiences

The Last of Us is a title that, despite the occasional moment that's frustrated ... but some also want games centered on a more real world, tales of struggle based around human endeavour, that also pu... read more

Profit from biotechnology – the saviour of Big Pharma

Big Pharma has two big problems: finding new drugs and fighting off copycats ... in the US. That means the worldwide market for copies of biotech medicines will grow to $3.7bn by 2015, from just $243m ... read more

Amgen Wins Reprieve on Its 2nd-Best-Selling Drug

That may mean it's only a matter of time before generic drug companies, including Mylan (NASDAQ: MYL), win FDA approval of biosimilar copycats. Unfortunately ... to $196 million. Amgen's struggle to m... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us